ATR and neuroblastoma: We have previously shown that MYCN-amplified cell lines are sensitive to ATR inhibitors (ATRi) [23] and increased sensitivity to CHK1 inhibition (a downstream target of ATR) in MYCN overexpressing NB cells has also been reported [24,25].